Home/Filings/4/0001127602-25-004459
4//SEC Filing

MCDONNELL MICHAEL R 4

Accession 0001127602-25-004459

CIK 0000875045other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:46 PM ET

Size

8.3 KB

Accession

0001127602-25-004459

Insider Transaction Report

Form 4
Period: 2025-02-10
MCDONNELL MICHAEL R
EVP, Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2025-02-10$142.54/sh1,371$195,42224,341 total
  • Exercise/Conversion

    Common Stock

    2025-02-10+3,25725,712 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-103,2570 total
    Exercise: $0.00Exp: 2025-02-10Common Stock (3,257 underlying)
Footnotes (1)
  • [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001121897

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:46 PM ET
Size
8.3 KB